Backgrounded Membrane Imaging (BMI), used by the HORIZON® particle analysis system, performs measurements of subvisible protein aggregates.
List view / Grid view
Filter the results
Read how Cyto-Mine® has helped improve overall efficiency and productivity in cell line development at FUJIFILM Diosynth Biotechnologies.
Hybridoma-based antibody discovery: the challenges and how to overcome them using microfluidic picodroplet technology.
In vitro evaluation of hepatic function using a primary human hepatocyte 3D spheroid culture system
Hypoxia measurements in live and fixed cells using fluorescence microscopy and high-content imaging
Are you missing the bigger picture with your AAV analytics? Sub-visible particle analysis shouldn’t require millilitres of precious sample.
Flow cytometry is a common technique used to identify different immune cell types in mixed population samples such as peripheral blood or tissue samples.
Enzyme Linked Immunosorbent Assays (ELISAs) are one of the most common immunoassays on the market.
When exosomes were first discovered they were thought to be nothing more than cellular waste containers, but it is now thought that the integral membrane proteins, soluble proteins, and nucleic acid contained within exosomes can be taken up by cells and influence their function.
Since 1976, R&D Systems, a Bio-Techne brand, has developed and manufactured high-quality reagents for the bio-scientific industry.
The Cubis® II balance, with pharma package, contains all the technical controls to support compliance with common regulations.
Application note: Integration of Sartorius Cubis® II Premium Balances into STARLIMS™ from Abbott Informatics
Laboratory Information Management Systems (LIMS) is becoming increasingly important in GMP regulated environments in order to ensure data integrity and faster working practices.
When your work demands unique reagents or scientific support, turn to the decades of product development legacy behind Bio-Techne’s trusted brands.
Chimeric antigen receptor (CAR) T cell transfer has had success as a treatment for leukemia and lymphoma, but solid tumors have been more challenging due to the rarity of true tumor-specific target molecules and the immunosuppressive nature of the tumor microenvironment.
Antibodies play a critical role in diagnostics and therapeutics. In these, and other applications, performance and consistency are critical.